Status:
COMPLETED
Fluorine-18-α-Methyltyrosine Positron Emission Tomography (18F-FMT PET) for Therapy Response in Lung Cancer
Lead Sponsor:
Gunma University
Collaborating Sponsors:
J~pharma
Conditions:
Non-Small Cell Lung Cancer
Eligibility:
All Genders
20+ years
Brief Summary
L-\[3-18F\]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for positron emission tomography (PET). The investigators evaluated the value of 18F-FMT PET for the assessment of therapy response in pa...
Eligibility Criteria
Inclusion
- primary lung cancer All patients received first-line chemotherapy
Exclusion
- Patients with diabetus mellitus
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00826033
Last Update
January 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gunma University Graduate School of Medicine
Gunma, Japan, 371-8511